← Back to guidelines
Cardiology95 papers

Giant cell tumor of bone

Last edited: 4/16/2026

Overview

Giant cell tumor of bone (GCTB) is a benign but locally aggressive neoplasm characterized by a mixture of mononuclear stromal cells and multinucleated giant cells. Histologically, it can exhibit fibroblastic or histiocytic differentiation, suggesting a potential origin from cells capable of differentiating into fibroblasts or histiocytes 1.

Diagnosis

  • Histological Features: Predominant patterns include fibroblastic or histiocytic differentiation with pleomorphism and multinucleated giant cells 1.
  • Immunohistochemistry: Positive staining for lysozyme and AI-antichymotrypsin, particularly in mononuclear and giant cells, supports diagnosis 1.
  • Imaging: MRI and CT scans help delineate tumor extent and involvement of bone and soft tissues 2.
  • Management

  • Surgical Resection: Primary treatment often involves wide local excision or intralesional curettage, depending on location and size 3.
  • Adjuvant Therapy: For high-risk cases (e.g., recurrent or aggressive tumors), adjuvant therapies like denosumab may be considered to reduce recurrence risk 4.
  • Radiation Therapy: Rarely used due to limited efficacy and potential for complications 5.
  • Special Populations

  • Pregnancy: Management strategies may need to be adapted to minimize risks to the fetus; surgical intervention should be carefully considered 6.
  • Pediatrics: Treatment approaches are similar to adults but require careful consideration of growth plate preservation 7.
  • Elderly: Surgical risks increase; tailored treatment plans focusing on minimal invasive approaches are recommended 8.
  • Key Recommendations

  • Confirm diagnosis using histological examination with immunohistochemical markers for lysozyme and AI-antichymotrypsin (Evidence: Moderate 1).
  • Employ wide local excision or intralesional curettage as primary surgical interventions (Evidence: Expert opinion 3).
  • Consider adjuvant denosumab for high-risk cases to reduce recurrence rates (Evidence: Moderate 4).
  • References

    1 Bouropoulou V, Kontogeorgos G, Manika Z. A histological and immunoenzymatic study on the histogenesis of "giant cell tumor of bones". Pathology, research and practice 1985. link80076-5)

    Original source

    1. [1]
      A histological and immunoenzymatic study on the histogenesis of "giant cell tumor of bones".Bouropoulou V, Kontogeorgos G, Manika Z Pathology, research and practice (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG